On 25 May 2016

Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 25 May 2016, to consider and approve the audited Financial Results for the year and quarter ended 31 March 2016

Powered by Capital Market - Live News

More From This Section

First Published: Mar 28 2016 | 5:38 PM IST

Next Story